rs146123023

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 4P and 9B. PVS1_StrongBP6BS1BS2

The ENST00000372499.5(LRMDA):​c.21delC​(p.Ser8AlafsTer14) variant causes a frameshift change. The variant allele was found at a frequency of 0.00287 in 1,614,100 control chromosomes in the GnomAD database, including 63 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0097 ( 20 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 43 hom. )

Consequence

LRMDA
ENST00000372499.5 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 6.86

Publications

9 publications found
Variant links:
Genes affected
LRMDA (HGNC:23405): (leucine rich melanocyte differentiation associated) This gene encodes a leucine-rich repeat protein. The encoded protein is thought to play a role in melanocyte differentiation. Mutations in this gene have been associated with autosomal recessive oculocutaneous albinism 7 (OCA7). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]
LRMDA Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 7
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 8 pathogenic variants in the truncated region.
BP6
Variant 10-75782995-TC-T is Benign according to our data. Variant chr10-75782995-TC-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 261988.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00974 (1483/152258) while in subpopulation AFR AF = 0.0289 (1201/41562). AF 95% confidence interval is 0.0275. There are 20 homozygotes in GnomAd4. There are 697 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRMDANM_001305581.2 linkc.132-253012delC intron_variant Intron 2 of 6 ENST00000611255.5 NP_001292510.1 A0A087WWI0
LRMDANM_032024.5 linkc.21delC p.Ser8AlafsTer14 frameshift_variant Exon 1 of 6 NP_114413.1 Q9H2I8
LRMDANR_131178.2 linkn.86-99660delC intron_variant Intron 1 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRMDAENST00000372499.5 linkc.21delC p.Ser8AlafsTer14 frameshift_variant Exon 1 of 6 1 ENSP00000361577.1 Q9H2I8
LRMDAENST00000611255.5 linkc.132-253012delC intron_variant Intron 2 of 6 5 NM_001305581.2 ENSP00000480240.1 A0A087WWI0
LRMDAENST00000593699.5 linkn.86-99660delC intron_variant Intron 1 of 7 1
LRMDAENST00000593817.1 linkn.92+181665delC intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.00975
AC:
1483
AN:
152140
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.0202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.00125
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00400
AC:
1003
AN:
251006
AF XY:
0.00346
show subpopulations
Gnomad AFR exome
AF:
0.0301
Gnomad AMR exome
AF:
0.00390
Gnomad ASJ exome
AF:
0.0177
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00141
Gnomad OTH exome
AF:
0.00555
GnomAD4 exome
AF:
0.00216
AC:
3152
AN:
1461842
Hom.:
43
Cov.:
32
AF XY:
0.00210
AC XY:
1525
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.0302
AC:
1010
AN:
33478
American (AMR)
AF:
0.00436
AC:
195
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0160
AC:
417
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86248
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53408
Middle Eastern (MID)
AF:
0.00936
AC:
54
AN:
5768
European-Non Finnish (NFE)
AF:
0.00101
AC:
1127
AN:
1112000
Other (OTH)
AF:
0.00551
AC:
333
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
175
350
524
699
874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00974
AC:
1483
AN:
152258
Hom.:
20
Cov.:
32
AF XY:
0.00936
AC XY:
697
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0289
AC:
1201
AN:
41562
American (AMR)
AF:
0.00595
AC:
91
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
70
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10616
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00125
AC:
85
AN:
68004
Other (OTH)
AF:
0.0119
AC:
25
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
74
147
221
294
368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000830
Hom.:
2
Bravo
AF:
0.0119
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRMDA: BS1, BS2 -

Feb 22, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.9
Mutation Taster
=31/169
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146123023; hg19: chr10-77542753; COSMIC: COSV100995385; API